Virome of a Feline Outbreak of Diarrhea and Vomiting Includes Bocaviruses and a Novel Chapparvovirus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ICTV Virus Taxonomy Profile: Parvoviridae
ICTV VIRUS TAXONOMY PROFILES Cotmore et al., Journal of General Virology 2019;100:367–368 DOI 10.1099/jgv.0.001212 ICTV ICTV Virus Taxonomy Profile: Parvoviridae Susan F. Cotmore,1,* Mavis Agbandje-McKenna,2 Marta Canuti,3 John A. Chiorini,4 Anna-Maria Eis-Hubinger,5 Joseph Hughes,6 Mario Mietzsch,2 Sejal Modha,6 Mylene Ogliastro,7 Judit J. Penzes, 2 David J. Pintel,8 Jianming Qiu,9 Maria Soderlund-Venermo,10 Peter Tattersall,1,11 Peter Tijssen12 and ICTV Report Consortium Abstract Members of the family Parvoviridae are small, resilient, non-enveloped viruses with linear, single-stranded DNA genomes of 4–6 kb. Viruses in two subfamilies, the Parvovirinae and Densovirinae, are distinguished primarily by their respective ability to infect vertebrates (including humans) versus invertebrates. Being genetically limited, most parvoviruses require actively dividing host cells and are host and/or tissue specific. Some cause diseases, which range from subclinical to lethal. A few require co-infection with helper viruses from other families. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the Parvoviridae, which is available at www.ictv.global/report/parvoviridae. Table 1. Characteristics of the family Parvoviridae Typical member: human parvovirus B19-J35 G1 (AY386330), species Primate erythroparvovirus 1, genus Erythroparvovirus, subfamily Parvovirinae Virion Small, non-enveloped, T=1 icosahedra, 23–28 nm in diameter Genome Linear, single-stranded DNA of 4–6 kb with short terminal hairpins Replication Rolling hairpin replication, a linear adaptation of rolling circle replication. Dynamic hairpin telomeres prime complementary strand and duplex strand-displacement synthesis; high mutation and recombination rates Translation Capped mRNAs; co-linear ORFs accessed by alternative splicing, non-consensus initiation or leaky scanning Host range Parvovirinae: mammals, birds, reptiles. -
Protoparvovirus Knocking at the Nuclear Door
viruses Review Protoparvovirus Knocking at the Nuclear Door Elina Mäntylä 1 ID , Michael Kann 2,3,4 and Maija Vihinen-Ranta 1,* 1 Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, FI-40500 Jyvaskyla, Finland; elina.h.mantyla@jyu.fi 2 Laboratoire de Microbiologie Fondamentale et Pathogénicité, University of Bordeaux, UMR 5234, F-33076 Bordeaux, France; [email protected] 3 Centre national de la recherche scientifique (CNRS), Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33076 Bordeaux, France 4 Centre Hospitalier Universitaire de Bordeaux, Service de Virologie, F-33076 Bordeaux, France * Correspondence: maija.vihinen-ranta@jyu.fi; Tel.: +358-400-248-118 Received: 5 September 2017; Accepted: 29 September 2017; Published: 2 October 2017 Abstract: Protoparvoviruses target the nucleus due to their dependence on the cellular reproduction machinery during the replication and expression of their single-stranded DNA genome. In recent years, our understanding of the multistep process of the capsid nuclear import has improved, and led to the discovery of unique viral nuclear entry strategies. Preceded by endosomal transport, endosomal escape and microtubule-mediated movement to the vicinity of the nuclear envelope, the protoparvoviruses interact with the nuclear pore complexes. The capsids are transported actively across the nuclear pore complexes using nuclear import receptors. The nuclear import is sometimes accompanied by structural changes in the nuclear envelope, and is completed by intranuclear disassembly of capsids and chromatinization of the viral genome. This review discusses the nuclear import strategies of protoparvoviruses and describes its dynamics comprising active and passive movement, and directed and diffusive motion of capsids in the molecularly crowded environment of the cell. -
To the Minister of Infrastructure and Water Management Mrs S. Van Veldhoven-Van Der Meer P.O. Box 20901 2500 EX the Hague Dear M
To the Minister of Infrastructure and Water Management Mrs S. van Veldhoven-van der Meer P.O. Box 20901 2500 EX The Hague DATE 21 March 2018 REFERENCE CGM/180321-01 SUBJECT Advice on the pathogenicity classification of AAVs Dear Mrs Van Veldhoven, Further to a request for advice concerning the dossier IG 18-028_2.8-000 titled ‘Production of and activities involving recombinant adeno-associated virus (AAV) vectors with modified capsids and capsids of wild type AAV serotypes absent from Appendix 4’, submitted by Arthrogen B.V., COGEM hereby notifies you of the following: Summary: COGEM was asked to advise on the pathogenicity classification of five adeno-associated viruses (AAVs): AAV10, AAV11, AAV12, AAVrh10 and AAVpo1. More than 100 AAVs have been isolated from various hosts. AAVs can infect vertebrates, including humans (95% of people have at one time or another been exposed to an AAV). AAVs are dependent on a helper virus to complete their life cycle. In the absence of a helper virus, the AAV genome persists in a latent form in the cell nucleus. So far no mention has been made in the literature of disease symptoms caused by an infection with AAVs. Neither have there been any reports of pathogenicity of AAV10, 11, 12, AAVrh10 or AAVpo1. AAV vectors are regularly used in clinical studies. Given the above information, COGEM recommends assigning AAV10, AAV11, AAV12, AAVrh10 and AAVpo1 as non-pathogenic to pathogenicity class 1. Based on the ubiquity of AAVs and the lack of evidence of pathogenicity, COGEM recommends that all AAVs belonging to the species Adeno-associated dependoparvovirus A and Adeno-associated dependoparvovirus B should be assigned to pathogenicity class 1. -
To the Minister for Infrastructure and Water Management Mrs C. Van Nieuwenhuizen-Wijbenga P.O. Box 20901 2500 EX the Hague Dear
To the Minister for Infrastructure and Water Management Mrs C. van Nieuwenhuizen-Wijbenga P.O. Box 20901 2500 EX The Hague DATUM 5 september 2019 KENMERK CGM/190905-01 ONDERWERP Advice 'Generic environmental risk assessment of clinical trials with AAV vectors' Dear Mrs Van Veldhoven, In the past COGEM has issued many advisory reports on gene therapy studies with AAV vectors. Armed with this knowledge, COGEM has drawn up a generic risk assessment for clinical applications of these vectors with the aim of streamlining the authorisation procedure for such trials. Summary: Hundreds of clinical trials have been carried out worldwide in which use was made of viral vectors derived from adeno-associated viruses (AAV). In recent years COGEM has published a large number of advisory reports on such trials, and in all these trials the risks to human health and the environment proved to be negligible. Drawing on these findings, COGEM has prepared a generic environmental risk assessment for clinical applications of AAV vectors. This generic environmental risk assessment can simplify and streamline the authorisation process. AAVs are non-pathogenic viruses that can only replicate in the presence of a helper virus. AAV vectors are stripped of all viral genes except the viral sequences at the ends of the genome, the inverted terminal repeats (ITRs). As a result, the vectors are unable to replicate even in the presence of a helper virus. COGEM therefore concludes that, given the characteristics of the AAV vectors used, the risks to human health and the environment posed by clinical trials with these vectors are negligible. -
Non-Invasive Surveys of Mammalian Viruses Using Environmental DNA
bioRxiv preprint doi: https://doi.org/10.1101/2020.03.26.009993; this version posted March 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title Non-invasive surveys of mammalian viruses using environmental DNA Highlights Environmental DNA (water and blood-sucking leeches) provided a non- invasive method of screening wildlife for viruses A comprehensive viral RNA oligonucleotide bait set was developed to capture known and unknown mammalian virus diversity Leech blood meal host determination and viruses identified were congruent Viruses determined from water correlated with known and observed species visiting the water sources In brief Alfano, Dayaram, et al. demonstrate that environmental DNA from southeast Asian leech bloodmeals and waterholes from Africa and Mongolia can be used as to detect viruses circulating in wildlife. These nucleic acid sources may represent an effective non-invasive resource for studying wildlife viral diversity and emerging viruses pre- emergence. bioRxiv preprint doi: https://doi.org/10.1101/2020.03.26.009993; this version posted March 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Non-invasive surveys of mammalian viruses using environmental DNA Niccolo Alfano1,2*, Anisha Dayaram3,4*, Jan Axtner1, Kyriakos Tsangaras5, Marie- Louise Kampmann1,6, Azlan Mohamed1,7, Seth T. -
Parvoviridae Hanafy .M.Madbouly Professor of Virology Faculty of Veterinary Medicine Beni-Suef University
Parvoviridae Hanafy .M.Madbouly Professor of Virology Faculty of Veterinary Medicine Beni-Suef University Definitions of the virus causative agents of several animal diseases. are most severe in fetuses and neonates. Parvovirus infections of the fetus or newborn during organogenesis may result in developmental defects. Replication of parvovirus is restricted in hemopoietic precursors, lymphocytes, and progenitor cells of intestinal mucosa of older animals. 2/38 Definitions of the virus cause acute infections for a few days, others persist for long periods in the feces of apparently robust host immune responses. Human Parvovirus B19 replication occurs only in human erythrocyte precursors The virus is found to survive in feces and other organic material such as soil for over 10 years. It survives extremely low and high temperatures. 3/38 Physical Properties of the virus . Family: Parvoviridae with two subfamilies . Parvovirinae. (vertebrate ). has 5 genera . Densovirinae. (invertebrate). Has3 genera .non-enveloped, 25 nm in diameter .Capsid: icosahederal. .Genome ssDNA Diseases caused by parvoviruses • As of 2014, there were no known human viruses in the remaining three recognized genera: • vi) Amdoparvovirus (e.g. Aleutian mink disease virus), • vii) Aveparvovirus (e.g. chicken parvovirus) and • viii) Copiparvovirus (e.g. bovine parvovirus 2). • Mouse parvovirus 1, however, causes no symptoms but can contaminate immunology experiments in biological research laboratories. • Porcine parvovirus causes a reproductive disease in swine known as SMEDI, which stands for stillbirth, mummification, embryonic death, and infertility. Diseases caused by parvoviruses • Many mammalian species sustain infection by multiple parvoviruses. • Feline panleukopenia is common in kittens and causes fever, low white blood cell count, diarrhea, and death. -
Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic: a Repo
Evidence to support safe return to clinical practice by oral health professionals in Canada during the COVID-19 pandemic: A report prepared for the Office of the Chief Dental Officer of Canada. November 2020 update This evidence synthesis was prepared for the Office of the Chief Dental Officer, based on a comprehensive review under contract by the following: Paul Allison, Faculty of Dentistry, McGill University Raphael Freitas de Souza, Faculty of Dentistry, McGill University Lilian Aboud, Faculty of Dentistry, McGill University Martin Morris, Library, McGill University November 30th, 2020 1 Contents Page Introduction 3 Project goal and specific objectives 3 Methods used to identify and include relevant literature 4 Report structure 5 Summary of update report 5 Report results a) Which patients are at greater risk of the consequences of COVID-19 and so 7 consideration should be given to delaying elective in-person oral health care? b) What are the signs and symptoms of COVID-19 that oral health professionals 9 should screen for prior to providing in-person health care? c) What evidence exists to support patient scheduling, waiting and other non- treatment management measures for in-person oral health care? 10 d) What evidence exists to support the use of various forms of personal protective equipment (PPE) while providing in-person oral health care? 13 e) What evidence exists to support the decontamination and re-use of PPE? 15 f) What evidence exists concerning the provision of aerosol-generating 16 procedures (AGP) as part of in-person -
An AAV-Based, Room-Temperature Stable, Single Dose COVID-19 Vaccine
bioRxiv preprint doi: https://doi.org/10.1101/2021.01.05.422952; this version posted January 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. An AAV-based, room-temperature stable, single dose COVID-19 vaccine Nerea Zabaleta1,2,3,4, Wenlong Dai1,2,3,4, Urja Bhatt1,2,3,4, Jessica A Chichester5, Julio Sanmiguel1,2,3,4, Reynette Estelien1,2,3,4, Kristofer T Michalson5, Cheikh Diop1,2,3,4, Dawid Maciorowski1,2,3,4, Wenbin Qi6, Elissa Hudspeth7, Allison Cucalon1,2,3,4, Cecilia D Dyer5, M. Betina Pampena5,8, James J. Knox9, Regina C LaRocque10,11, Richelle C Charles10,11, Dan Li1,2,3,4, Maya Kim1,2,3,4, Abigail Sheridan1,2,3,4, Nadia Storm12, Rebecca I Johnson12, Jared Feldman13, Blake M Hauser13, Aisling Ryan1,2,3,4, Eric Zinn1,2,3,4, Dione T Kobayashi14, Ruchi Chauhan1,2,3,4, Marion McGlynn5, Edward T Ryan10,11,15, Aaron G Schmidt13,16, Brian Price17, Anna Honko12, Anthony Griffiths12, Sam Yaghmour6, Robert Hodge18, Michael R. Betts5,8, Mason W Freeman19, James M Wilson5, Luk H Vandenberghe1,2,3,4,* 1 Grousbeck Gene Therapy Center, Schepens Eye Research Institute, Mass Eye and Ear, Boston, Massachusetts, USA 2 Ocular Genomics Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA 3 The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA 4 Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA 5Gene Therapy Program, Perelman School of Medicine, University -
Evolutionary Background Entities at the Cellular and Subcellular Levels in Bodies of Nonhuman Vertebrate Animals
The Journal of Theoretical Fimpology Volume 2, Issue 3: e-20081017-2-3-13 December 23, 2014 www.fimpology.com Evolutionary Background Entities at the Cellular and Subcellular Levels in Bodies of Nonhuman Vertebrate Animals Shu-dong Yin Cory H. E. R. & C. Inc. Burnaby, British Columbia, Canada Email: [email protected] ________________________________________________________________________ Abstract During the past two decades, it has been revealed by culture-independent approaches that individual bodies of normal animals are actually inhabited by subcellular viral entities and membrane-enclosed microentities, prokaryotic bacterial and archaeal cells, and unicellular eukaryotes such as fungi and protists. And however, the relationship between animals including human beings and their environmental microentities or microorganisms reflected in such phenomenon cannot be accounted for by our traditional pathogenic recognition in human medicine and veterinary medicine. It’s well known that as one of humans’ environmental macroorganisms, some nonhuman animal species were initially concerned for their practical values in nutrition, medicine and economy, and have been studied within the scope of traditional macro-biology for a long time and that our primary interest on the microorganisms of nonhuman animals was for their potential risk of zoonotic transmission of pathogenetic bacteria and viruses from animals to humans. In recent novel evolution theories, the relationship between animals and their environments has been deciphered to be the interaction -
Specific Detection of Muscovy Duck Parvovirus Infection by Taqman
Wan et al. BMC Veterinary Research (2018) 14:267 https://doi.org/10.1186/s12917-018-1600-3 RESEARCHARTICLE Open Access Specific detection of Muscovy duck parvovirus infection by TaqMan-based real-time PCR assay Chunhe Wan* , Cuiteng Chen, Longfei Cheng, Hongmei Chen, Qiuling Fu, Shaohua Shi, Guanghua Fu, Rongchang Liu and Yu Huang* Abstract Background: Muscovy duck parvovirus (MDPV) causes high mortality and morbidity in Muscovy ducks, with the pathogenesis of the virus still unknown in many respects. Specific MDPV detection is often rife with false positive results because of high identity at the genomic nucleotide level and antigenic similarity with goose parvovirus (GPV). The objective of this study was to develop a sensitive, highly specific, and repeatable TaqMan-based real-time PCR (qPCR) assay for facilitating the molecular detection of MDPV. Results: The specific primers and probe were designed based on the conserved regions within MDPVs, but there was a variation in GPVs of the nonstructural (NS) genes after genetic comparison. After the optimization of qPCR conditions, the detection limit of this qPCR assay was 29.7 copies/μl. The assay was highly specific for the detection of MDPV, and no cross-reactivity was observed with other non-targeted duck-derived pathogens. Intra- and inter-assay variability was less than 2.21%, means a high degree of repeatability. The diagnostic applicability of the qPCR assay was proven that MDPV-positive can be found in cloacal swabs samples, Muscovy duck embryos and newly hatched Muscovy ducklings. Conclusions: Our data provided incidents that MDPV could be possible vertically transmitted from breeder Muscovy ducks to Muscovy ducklings. -
Viral Vector Platforms Within the Gene Therapy Landscape
University of Massachusetts Medical School eScholarship@UMMS Open Access Publications by UMMS Authors 2021-02-08 Viral vector platforms within the gene therapy landscape Jote T. Bulcha University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Genetics and Genomics Commons, and the Therapeutics Commons Repository Citation Bulcha JT, Wang Y, Ma H, Tai PW, Gao G. (2021). Viral vector platforms within the gene therapy landscape. Open Access Publications by UMMS Authors. https://doi.org/10.1038/s41392-021-00487-6. Retrieved from https://escholarship.umassmed.edu/oapubs/4621 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN Viral vector platforms within the gene therapy landscape Jote T. Bulcha1,2, Yi Wang3, Hong Ma1, Phillip W. L. Tai 1,2,4 and Guangping Gao1,2,5 Throughout its 40-year history, the field of gene therapy has been marked by many transitions. It has seen great strides in combating human disease, has given hope to patients and families with limited treatment options, but has also been subject to many setbacks. Treatment of patients with this class of investigational drugs has resulted in severe adverse effects and, even in rare cases, death. -
Viral Component of the Human Genome V
ISSN 0026-8933, Molecular Biology, 2017, Vol. 51, No. 2, pp. 205–215. © Pleiades Publishing, Inc., 2017. Original Russian Text © V.M. Blinov, V.V. Zverev, G.S. Krasnov, F.P. Filatov, A.V. Shargunov, 2017, published in Molekulyarnaya Biologiya, 2017, Vol. 51, No. 2, pp. 240–250. REVIEWS UDC 578.264.9 Viral Component of the Human Genome V. M. Blinova, V. V. Zvereva, G. S. Krasnova, b, c, F. P. Filatova, d, *, and A. V. Shargunova aMechnikov Research Institute of Vaccines and Sera, Moscow, 105064 Russia bEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 111911 Russia cOrekhovich Research Institute of Biomedical Chemistry, Moscow, 119121 Russia dGamaleya Research Center of Epidemiology and Microbiology, Moscow, 123098 Russia *e-mail: [email protected] Received December 27, 2015; in final form, April 27, 2016 Abstract⎯Relationships between viruses and their human host are traditionally described from the point of view taking into consideration hosts as victims of viral aggression, which results in infectious diseases. How- ever, these relations are in fact two-sided and involve modifications of both the virus and host genomes. Mutations that accumulate in the populations of viruses and hosts may provide them advantages such as the ability to overcome defense barriers of host cells or to create more efficient barriers to deal with the attack of the viral agent. One of the most common ways of reinforcing anti-viral barriers is the horizontal transfer of viral genes into the host genome. Within the host genome, these genes may be modified and extensively expressed to compete with viral copies and inhibit the synthesis of their products or modulate their functions in other ways.